“A Prospective, Randomized and Double Blind Once-Monthly Oral Ibandronate and Risedronate in Post-Menopausal Osteoporosis Leprosy Patients”. 2017. International Journal of Biomedical and Advance Research 8 (11): 407-15. https://doi.org/10.7439/ijbar.v8i11.4474.